Save time and jump to the most important pieces.
Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/2/2024 | $29.00 | Outperform | Leerink Partners | |
12/5/2023 | $38.00 | Overweight | KeyBanc Capital Markets | |
11/14/2023 | $356.00 → $295.00 | Buy → Underperform | BofA Securities | |
5/5/2023 | $60.00 | Overweight | Piper Sandler | |
12/19/2022 | $23.00 | Neutral | Goldman | |
12/14/2022 | $281.00 → $295.00 | Neutral → Outperform | Robert W. Baird | |
10/24/2022 | $295.00 → $270.00 | Neutral → Buy | Rosenblatt | |
9/16/2022 | $275.00 | Underweight → Overweight | JP Morgan |
10-Q - ANSYS INC (0001013462) (Filer)
8-K - ANSYS INC (0001013462) (Filer)
425 - ANSYS INC (0001013462) (Subject)
4 - ANSYS INC (0001013462) (Issuer)
4 - Schrodinger, Inc. (0001490978) (Issuer)
4 - ANSYS INC (0001013462) (Issuer)
Ansys Inc (NASDAQ:ANSS) is partnering with artificial intelligence server company Super Micro Computer, Inc (NASDAQ:SMCI) and Nvidia Corp (NASDAQ:NVDA) to provide turnkey hardware solutions that dramatically accelerate Ansys multiphysics simulation capabilities. Ansys creates and sells engineering simulation software that helps users make quicker, informed decisions, enhance product and system designs, and optimize workflows throughout the product life cycle. By integrating hardware and software, Ansys aims to help customers solve more significant and more complex models up to 1,600 times faster. This collaboration enhances the speed and efficiency of simulations, reducing time-
Collaboration optimizes Ansys solutions and AI capabilities, boosts simulation speeds up to 1,600x/ Key HighlightsTurnkey hardware optimized for Ansys multiphysics simulation provides flexible configurations through collaborations with Supermicro and NVIDIASupercharged simulation reduces time-to-market and facilitates rich design exploration for automotive crash testing and external aerodynamics, aerospace gas turbine engines, 5G/6G antennas, biopharmaceutical development, and moreAnsys' open ecosystem streamlines integration of diverse technologies within its multiphysics platformPITTSBURGH, Pa., July 18, 2024 /PRNewswire/ -- Ansys (NASDAQ:ANSS) is collaborating with Supermicro and NVIDIA t
/ Q3 2024 Results Revenue of $601.9 millionGAAP diluted earnings per share of $1.46 and non-GAAP diluted earnings per share of $2.58GAAP operating profit margin of 26.8% and non-GAAP operating profit margin of 45.8%Operating cash flows of $174.2 million and unlevered operating cash flows of $184.5 millionAnnual contract value (ACV) of $540.5 millionDeferred revenue and backlog of $1,463.8 million on September 30, 2024 PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ANSYS, Inc. (NASDAQ:ANSS), today reported third quarter 2024 revenue of $601.9 million, an increase of 31% in reported and constant currency when compared to the third quarter of 2023. For the third quarter of 2024, the Company
IonQ and Ansys partner to enhance engineering simulation through advanced quantum computing Key Highlights The computer-aided engineering (CAE) market can benefit from the ability of IonQ quantum computers to accelerate simulation, allowing Ansys customers to perform more complex simulations and bring better products to market faster. New partnership aims to allow expert and non-expert users to seamlessly access the power of IonQ's quantum computers to improve product development processes. IonQ will use Ansys simulation solutions to design its next-generation quantum computers and quantum networks for increased scalability and performance. IonQ (NYSE:IONQ), a leader in the quantum
Schrödinger (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 20, at 8:30 a.m. GMT (3:30 a.m. ET). The live webcast can be accessed in the "Investors" section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-
Leerink Partners initiated coverage of Schrodinger with a rating of Outperform and set a new price target of $29.00
KeyBanc Capital Markets initiated coverage of Schrodinger with a rating of Overweight and set a new price target of $38.00
BofA Securities downgraded ANSYS from Buy to Underperform and set a new price target of $295.00 from $356.00 previously
SC 13G/A - Schrodinger, Inc. (0001490978) (Subject)
SC 13G/A - ANSYS INC (0001013462) (Subject)
SC 13G/A - Schrodinger, Inc. (0001490978) (Subject)
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company's Board of Directors (the "Board"), effective on October 28, 2024. Each of Mr. Fernandez, Mr. Frankola, and Mr. Jensen have been appointed to serve as members of the Board's Audit Committee and Compensation Committee, with Mr. Fernandez serving as the Chair of the Audit Committee and Mr. Jensen serving as the Chair of the Compensation Committee. In additio
Seasoned HR professional brings decades of experience to global leader and innovator of engineering simulation software / Key Highlights Kathleen Weslock named as Vice President of Human Resources at AnsysWeslock brings decades of experience in fostering corporate cultures and ability to scale HR organizationsPITTSBURGH, June 26, 2023 /PRNewswire/ -- Ansys (NASDAQ:ANSS) has named Kathleen Weslock, an industry veteran with decades of experience in human resources, labor relations, and mergers and acquisitions, as its vice president of human resources. Prior to joining Ansys, We
Addition of new director strengthens executive expertise in financial and strategic planning, digital transformation, and mergers and acquisitions / Key HighlightsClaire Bramley appointed to Ansys Board of DirectorsBramley has decades of financial experience including global transformations and M&APITTSBURGH, Dec. 16, 2022 /PRNewswire/ -- Ansys (NASDAQ:ANSS) today announced that Claire Bramley accepted an appointment to the Ansys Board of Directors, effective December 15, 2022 – bringing deep expertise in leading large-scale fiscal and operational disciplines; driving financial and strategic planning; and managing complex mergers and acquisitions (M&A).
Schrödinger (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2024 financial results on Tuesday, November 12, 2024, before the financial markets open. The company will host a conference call and webcast at 8:00 a.m. ET. The live webcast can be accessed in the "Investors" section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules
PITTSBURGH, Oct. 17, 2024 /PRNewswire/ -- ANSYS, Inc. (NASDAQ:ANSS) announced today that the Company expects to release its third quarter earnings on Wednesday, November 6, 2024, after the market closes. As previously announced, in light of the pending transaction with Synopsys, Inc. (Synopsys), Ansys has suspended quarterly earnings conference calls and no longer provides quarterly or annual guidance. After the market closes on Wednesday, November 6, 2024, you can find the following information on the investor section of our website at https://investors.ansys.com: the earning
Second Quarter Total Revenue of $47.3 Million, Software Revenue of $35.4 Million Launches Major Initiative to Expand Application of Computational Tools for Predictive Toxicology Initial Clinical Data Expected for SGR-1505 in 1H25, SGR-2921 and SGR-3515 Data in 2H25 Schrödinger, Inc. (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced financial results for the second quarter of 2024. "We are very pleased with our results for the second quarter. We delivered 21% software revenue growth, and we see many opportunities for customers to increase their scale of adoption of our technology. Our recently